Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
Centro de investigación
Instituto de Química Avanzada de Cataluña
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Instituto de Química Avanzada de Cataluña (9)
2023
-
Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression
Arthritis Research and Therapy, Vol. 25, Núm. 1
-
Semisynthetic Pneumococcal Glycoconjugate Nanovaccine
Bioconjugate Chemistry, Vol. 34, Núm. 9, pp. 1563-1575
2021
-
Biodistribution of 68/67Ga-radiolabeled sphingolipid nanoemulsions by pet and spect imaging
International Journal of Nanomedicine, Vol. 16, pp. 5923-5935
2020
-
Biocompatible Nanovector of siRNA Consisting of Arginine-Based Cationic Lipid for Gene Knockdown in Cancer Cells
ACS Applied Materials and Interfaces, Vol. 12, Núm. 31, pp. 34536-34547
-
Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6
Journal of Medicinal Chemistry, Vol. 63, Núm. 17, pp. 9360-9390
-
Protein expression knockdown in cancer cells induced by a gemini cationic lipid nanovector with histidine-based polar heads
Pharmaceutics, Vol. 12, Núm. 9, pp. 1-22
2018
-
Ghrelin Causes a Decline in GABA Release by Reducing Fatty Acid Oxidation in Cortex
Molecular Neurobiology, Vol. 55, Núm. 9, pp. 7216-7228
2015
-
New selective A2A agonists and A3 antagonists for human adenosine receptors: synthesis, biological activity and molecular docking studies
MedChemComm, Vol. 6, Núm. 6, pp. 1178-1185
2010
-
Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease
Progress in Lipid Research, Vol. 49, Núm. 4, pp. 316-334